Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 902

1.

Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.

Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, Sturm AW, Gandhi NR.

Am J Respir Crit Care Med. 2011 May 15;183(10):1427-33. doi: 10.1164/rccm.201009-1449OC. Epub 2011 Feb 4.

PMID:
21297071
2.

Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.

Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J.

J Antimicrob Chemother. 2015 Feb;70(2):456-62. doi: 10.1093/jac/dku384. Epub 2014 Sep 28.

PMID:
25266071
3.

Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.

Makamure B, Mhaka J, Makumbirofa S, Mutetwa R, Mupfumi L, Mason P, Metcalfe JZ.

PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11.

4.

Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.

Dang TM, Nguyen TN, Wolbers M, Vo SK, Hoang TT, Nguyen HD, To MH, Vuong MB, Nguyen TP, Tran VQ, Nguyen TB, Vo TH, Nguyen TN, Dai VH, Phan TH, Nguyen HD, Farrar J, Caws M.

BMC Infect Dis. 2012 Mar 1;12:49. doi: 10.1186/1471-2334-12-49.

5.

A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.

Solomon S, Balakrishnan P, Vignesh R, Waldrop G, Solomon SS, Murugavel KG, Kumarasamy N, Yepthomi T, Poongulali S, Swathirajan CR, Sreenivasan V, Chandrasekar C, Suriakumar J, Mahilmaran A, Manoharan G, Moore DA.

Indian J Med Microbiol. 2013 Apr-Jun;31(2):130-7. doi: 10.4103/0255-0857.115225.

6.

Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.

Lazarus RP, Kalaiselvan S, John KR, Michael JS.

Indian J Med Microbiol. 2012 Jan-Mar;30(1):64-8. doi: 10.4103/0255-0857.93039.

7.

Microscopic observation drug susceptibility assay in the diagnosis of multidrug-resistant tuberculosis.

Rasslan O, Hafez SF, Hashem M, Ahmed OI, Faramawy MA, Khater WS, Saleh DA, Mohamed MI, Khalifa MA, Shoukry FA, El-Moghazy EH.

Int J Tuberc Lung Dis. 2012 Jul;16(7):941-6. doi: 10.5588/ijtld.11.0547. Epub 2012 May 7.

PMID:
22584201
8.

Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.

Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E.

J Clin Microbiol. 2007 Apr;45(4):1093-7. Epub 2007 Jan 24.

9.

Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.

Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E.

Int J Tuberc Lung Dis. 2008 Mar;12(3):332-7.

PMID:
18284841
10.

Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.

Lora MH, Reimer-McAtee MJ, Gilman RH, Lozano D, Saravia R, Pajuelo M, Bern C, Castro R, Espinoza M, Vallejo M, Solano M, Challapa R, Torrico F.

BMC Infect Dis. 2015 Jun 6;15:222. doi: 10.1186/s12879-015-0966-0.

11.

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME.

Am J Respir Crit Care Med. 2008 Apr 1;177(7):787-92. doi: 10.1164/rccm.200709-1436OC. Epub 2008 Jan 17.

PMID:
18202343
12.

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.

PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4.

13.

Microscopic-observation drug-susceptibility assay for the diagnosis of TB.

Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Piñedo Y, Saravia JC, Salazar C, Oberhelman R, Hollm-Delgado MG, LaChira D, Escombe AR, Friedland JS.

N Engl J Med. 2006 Oct 12;355(15):1539-50.

14.

Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda.

Bwanga F, Haile M, Joloba ML, Ochom E, Hoffner S.

PLoS One. 2011 May 9;6(5):e19565. doi: 10.1371/journal.pone.0019565.

15.

Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay.

Ha DT, Lan NT, Kiet VS, Wolbers M, Hang HT, Day J, Hien NQ, Tien NA, An PT, Anh TT, Oanh do TT, Hoa CL, Chau NT, Hai NN, Binh NT, Ngoc le H, Phuong DT, Quyet TV, Tuyen NT, Ha VT, Nho NT, Hoa DV, Anh PT, Dung NH, Farrar J, Caws M.

J Clin Microbiol. 2010 Dec;48(12):4573-9. doi: 10.1128/JCM.00687-10. Epub 2010 Oct 6.

16.

[Evaluation of microscopic observation drug susceptibility for drug susceptibility testing of mycobacterium tuberculosis in smear-positive sputum].

Lu JM, Wang J, Huang XC, Hu ZY, Cui ZL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Jan;45(1):21-5. Chinese.

PMID:
21418814
17.

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, Soto G, Serpa J; Tuberculosis Working Group in Peru.

J Clin Microbiol. 2004 Oct;42(10):4432-7.

18.

Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis.

Minion J, Leung E, Menzies D, Pai M.

Lancet Infect Dis. 2010 Oct;10(10):688-98. doi: 10.1016/S1473-3099(10)70165-1. Epub 2010 Aug 31. Review.

PMID:
20813587
19.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel J, Roper MH, Herrera C, Bonilla C, Jave O, Gianella C, Sabogal I, Huancaré V, Leo E, Tyas A, Mendoza-Ticona A, Caviedes L, Moore DA.

Clin Microbiol Infect. 2014 Jun;20(6):536-41. doi: 10.1111/1469-0691.12401. Epub 2013 Nov 21.

20.

Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.

Nishiyama H, Aono A, Sugamoto T, Mizuno K, Chikamatsu K, Yamada H, Mitarai S.

J Microbiol Methods. 2014 Jun;101:44-8. doi: 10.1016/j.mimet.2014.03.014. Epub 2014 Apr 6.

PMID:
24717372

Supplemental Content

Support Center